Labshake search
Citations for R&D Systems :
3251 - 3300 of 4069 citations for 3 Methoxy 2 2 4 4 Tetrabde Unlabeled 50 Ug Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... Wells were coated with 5μg/ml of either rhICAM/Fc chimera (R&D Systems) or rhVCAM/Fc chimera (R&D Systems ...
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Bioengineering 2019Quote: ... groove multiwell array were coated with human fibronectin (10 μg/ml, R&D Systems) for 1 hour ...
-
bioRxiv - Cell Biology 2019Quote: ... 100µl of 10 µg/ml fibronectin or E-Cadherin (R&D System, 8875-EC) was applied to a 2X2 cm NoA 74 membrane on a polymer bottom dish (ibidi ...
-
bioRxiv - Cell Biology 2020Quote: ... and were treated with 10 ng/mL TGF-β1 (R&D systems, 240-B) or IMRC conditioned medium where specified ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Biochemistry 2021Quote: ... and 30 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems, USA) at 37°C and 5% CO2 for 3 days ...
-
bioRxiv - Developmental Biology 2021Quote: ... Cells were resuspended in differentiation media supplemented with 1ng/ml BMP4 (R&D Systems), filtered and counted using a hemocytometer ...
-
bioRxiv - Developmental Biology 2021Quote: ... media was changed to differentiation media supplemented with 5ng/ml VEGF (R&D Systems) and cells were fed every 2 days until they reached confluence (approximately Ddy 22) ...
-
bioRxiv - Developmental Biology 2021Quote: ... Cells were resuspended in differentiation media supplemented with 100ng/ml VEGF (R&D Systems) and 50ng/ml bFGF (R&D Systems) ...
-
bioRxiv - Cancer Biology 2021Quote: ... and immunostained with goat anti-AREG antibody (15 μg/mL; AF262, R&D Systems) or rabbit anti-cleaved AREG 1A3 antibody (10 μg/mL ...
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Immunology 2020Quote: ... supplemented with murine M-CSF (20 ηg/mL; R&D Systems, Minneapolis, MN, USA) diluted in DMEM-High (Invitrogen ...
-
bioRxiv - Microbiology 2020Quote: ... cells were then fed with 20ng/ml human BMP4 (R&D Systems, PRD314-10), 0.5µM all-trans retinoic acid (ATRA ...
-
bioRxiv - Immunology 2021Quote: ... tumor necrosis factor (TNF)-α (25 ng/mL; R&D Systems Cat# 210-TA), and polyinosinic:polycytidylic acid (20 ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... Fibroblasts were stimulated with 10 ng/mL TNF-α (210-TA; R&D Systems) and 10 ng/mL IFN-γ (285-IF ...
-
bioRxiv - Immunology 2020Quote: ... R&D systems)26 or alternative activated (regulatory) M2 macrophages (40 ng/mL IL4;R&D systems)26 ...
-
bioRxiv - Cell Biology 2021Quote: ... Recombinant Mouse sFRP-1 Protein (1 µg/ml, R&D Systems, MN9019-SF-025), Plexin-D1 Fc fragment (30 µg/ml) ...
-
bioRxiv - Immunology 2022Quote: ... and 25 ng/mL human recombinant M-CSF (#216-MC, R&D Systems Inc). Cells were differentiated for 7-10 days prior to treatment as has previously been shown to yield mature macrophages (44) ...
-
bioRxiv - Biophysics 2022Quote: ... 0.004% (40 ng/mL) basic fibroblast growth factor (R&D Systems, 233-FB/CF), 1× non-essential amino acids ...
-
bioRxiv - Molecular Biology 2022Quote: ... the transfected cells were treated with 5 ng/ml TGF-β1 (R&D Systems) for 24 hours ...
-
bioRxiv - Biophysics 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript ...
-
bioRxiv - Neuroscience 2023Quote: ... GDNF (anti-goat-GDNF; AF-212-NA, 0.2µg/ml, R&D Systems, Minneapolis, MN), GFR-α1 (anti-goat-GFR-α1 ...
-
bioRxiv - Neuroscience 2023Quote: ... GFR-α1 (anti-goat-GFR-α1; AF560; 1µg/ml; R&D Systems, Minneapolis, MN), RET (anti-rabbit-RET ...
-
bioRxiv - Immunology 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript).
-
bioRxiv - Developmental Biology 2022Quote: ... and supplemented with the growth factors EGF (20 ng ml−1; R&D Systems) and FGF2 (20 ng ml−1 ...
-
bioRxiv - Cell Biology 2022Quote: ... and stimulated with 25 ng/mL macrophage colony-stimulating factor (MCSF, R&D Systems). After two days ...
-
bioRxiv - Cell Biology 2023Quote: ... Bound TRAIL was stained with goat anti-mTRAIL (1ug/ml, AF1121, R&D systems) or goat anti-hTRAIL (1ug/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... and TGFβ (0 or 10 ng/ml; rhTGF-beta1; R&D Systems, Minneapolis, MN) were added to the medium ...
-
bioRxiv - Bioengineering 2024Quote: ... CM was supplemented with anti-TNFR1 (10 µg/mL, MAB225-500, R&D Systems), anti-TNFR2 (10 µg/mL ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Bioengineering 2024Quote: ... which was supplemented with 10 ng/mL human activin A (R&D Systems, Inc.), 5 ng/mL human Bmp4 (R&D Systems ...
-
bioRxiv - Cell Biology 2024Quote: ... and recombinant human or murine Fc-ICAM-1 (10 μg/ml) (R&D Systems) coated plates ...
-
bioRxiv - Molecular Biology 2024Quote: ... and incubated in media containing recombinant 50ng/mL hEGF (R&D Systems Minneapolis, MN), 100ng/mL hNoggin (Shenandoah Warminster ...
-
bioRxiv - Developmental Biology 2024Quote: ... supplemented with 1 ng/ml human Activin A (R&D Systems Cat#. 338-AC) and 1 ng/ml human BMP4 (R&D Systems Cat# 314-BP) ...
-
bioRxiv - Neuroscience 2024Quote: ... and 20 ng ml−1 basic fibroblast growth factor (R&D Systems, 233-FB), with every day medium change for another 8 days ...
-
bioRxiv - Genetics 2023Quote: ... 40 ng ml–1 glial cell line-derived neurotrophic factor (GDNF, R&D Systems), 200 µM ascorbic acid (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were stimulated with 100 ng/mL recombinant WNT3A (R&D Systems, 5036-WN) or WNT5A (R&D Systems ...
-
bioRxiv - Genomics 2024Quote: ... cells were also treated with or without TNFα (R&D systems, 100 ng/ml) at 48 h after transfection and harvested at 72 h after transfection (24 h after TNFα treatment).
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Cell Biology 2024Quote: ... containing 5 µg/ml rDLK1 resuspended in PBS (R&D Systems, #1144-PR-025) or PBS vehicle ...
-
bioRxiv - Cancer Biology 2023Quote: ... IL-6 (406-ML) and LIF (8878-LF) were purchased from R&D Systems. JAK1/2 inhibitor Ruxolitinib was obtained from (Abcam ...
-
bioRxiv - Immunology 2023Quote: ... in media containing 10 ng/ml IL-7 (BT-007-010; R&D Systems) at 37°C in 5% CO2 and after 3.5 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... in the presence or absence of 300 pg/ml rm-IL21 (R&D Systems). The next day ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 5 ng/ml RANKL (R&D Systems Catalog #462-TEC-010; Lot # CWA2622011), which is the previously reported EC50 needed for primary bone marrow cell differentiation into osteoclasts ...
-
bioRxiv - Neuroscience 2023Quote: ... The medium was supplemented daily with bFGF 20ng/ml (233-FB, R&D Systems), RA 1µg/ml (R2625 ...
-
bioRxiv - Biophysics 2023Quote: ... and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ, R&D Systems) (Farnsworth et al. ...
-
bioRxiv - Bioengineering 2023Quote: ... and Cetuximab (Alex Fluor 647-conjugated, #FAB9577R, 0.1 mg mL-1, R&D Systems). The permeability analysis also yields the morphological parameters measured46 ...
-
bioRxiv - Immunology 2023Quote: ... BMDMs were treated with recombinant mouse SPARCL1 (5-20 μg/ml, R&D system, #4547-SL ...